Tissue repair-focused developer LifeBond said today it launched a pivotal study of its LifeSeal surgical sealant kit, set to explore the use of the sealant in patients undergoing colorectal anastomosis. The Israel-based company’s LifeSeal surgical sealant kit includes a specific gastrointestinal sealant designed to minimize staple-line leakage during gastrointestinal resection procedures. “LifeBond’s team is committed to bringing […]
LifeBond
LifeBond wins FDA IDE clearance for LifeSeal sealant kit
LifeBond said today it won an Investigational Device Exemption from the FDA to initiate a clinical study of its LifeSeal surgical sealant kit. The company’s LifeSeal kit includes a specific gastrointestinal sealant deisgned to minimize staple-line leakage during gastrointestinal resection procedures. “Given the associated challenges and complications of low anterior resections (LAR), developing a sealant […]
LifeBond wins CE Mark, FDA fast track for LifeSeal surgical sealant
LifeBond said today that it won CE Mark approval in the European Union for its LifeSeal surgical sealant for gastrointestinal resection procedures, and got on the fast track with the FDA for the surgical sealant. LifeSeal is designed to minimize staple-line leakage during anastomosis or linear surgical repair of the GI tract, Caesarea, Israel-based LifeBond said. […]
LifeBond closes $27m Series D
Bio-surgical medical device company LifeBond said today it closed a $27 million Series D equity round, with funds slated to support its flagship LifeSeal surgical sealant. Funds came from Pitango Venture Capital, Adams Street Partners, Sino Biopharmaceutical Ltd and existing investors, the company said. “LifeSeal is a novel product that addresses an urgent unmet need […]
